Abstract:ABSTRACT Hepatitis C virus (HCV) entry involves binding to cell surface heparan sulfate (HS) structures. However, due to the lipoprotein-like structure of HCV, the exact contribution of virion components to this interaction remains controversial. Here, we investigated the relative contribution of HCV envelope proteins and apolipoprotein E in the HS-binding step. Deletion of hypervariable region 1, a region previously proposed to be involved in HS binding, did not alter HCV virion binding to HS, indicating that this region is not involved in this interaction in the context of a viral infection. Patient sera and monoclonal antibodies recognizing different regions of HCV envelope glycoproteins were also used in a pulldown assay with beads coated with heparin, a close HS structural homologue. Although isolated HCV envelope glycoproteins could interact with heparin, none of these antibodies was able to interfere with the virion-heparin interaction, strongly suggesting that at the virion surface, HCV envelope glycoproteins are not accessible for HS binding. In contrast, results from kinetic studies, heparin pulldown experiments, and inhibition experiments with anti-apolipoprotein E antibodies indicated that this apolipoprotein plays a major role in HCV-HS interaction. Finally, characterization of the HS structural determinants required for HCV infection by silencing of the enzymes involved in the HS biosynthesis pathway and by competition with modified heparin indicated that N- and 6-O-sulfation but not 2-O-sulfation is required for HCV infection and that the minimum HS oligosaccharide length required for HCV infection is a decasaccharide. Together, these data indicate that HCV hijacks apolipoprotein E to initiate its interaction with specific HS structures. IMPORTANCE Hepatitis C is a global health problem. Hepatitis C virus (HCV) infects approximately 130 million individuals worldwide, with the majority of cases remaining undiagnosed and untreated. In most infected individuals, the virus evades the immune system and establishes a chronic infection. As a consequence, hepatitis C is the leading cause of cirrhosis, end-stage liver disease, hepatocellular carcinoma, and liver transplantation. Virus infection is initiated by entry of the virus into the host cell. In this study, we provide new insights into the viral and cellular determinants involved in the first step of HCV entry, the binding of the virus to host cells. We show that apolipoprotein E is likely responsible for virus binding to heparan sulfate and that N- and 6-O-sulfation of the heparan sulfate proteoglycans is required for HCV infection. In addition, the minimal HS length unit required for HCV infection is a decasaccharide.

Specifically Binding of L-ficolin to N-glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation.

Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients.

Ficolin-2 Inhibits Hepatitis C Virus Infection, Whereas Apolipoprotein E3 Mediates Viral Immune Escape.

Human L-ficolin Can Bind and Defence Against Multiple Pathogens (89.29)

ApoE3 blocks HCV entry inhibitor ficolin-2 (INM8P.437)

L-Ficolin Binds to the Glycoproteins Hemagglutinin and Neuraminidase and Inhibits Influenza A Virus Infection Both in Vitro and in Vivo

Serum ficolin-2 concentrations are significantly changed in patients with hepatitis B virus infection and liver diseases

High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection

Ficolin-2 Binds to HIV-1 Gp120 and Blocks Viral Infection

Human M-ficolin is a secretory protein that activates the lectin complement pathway.

Ficolins and Infectious Diseases

Low Mannose Binding Lectin, but Not L-Ficolin, is Associated with Spontaneous Clearance of Hepatitis C Virus after Infection

DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2*

C5aR, TNF-α, and FGL2 Contribute to Coagulation and Complement Activation in Virus-Induced Fulminant Hepatitis.

Purification, Measurement of Concentration, and Functional Complement Assay of Human Ficolins

C-type Lectin LSECtin Interacts with DC-SIGNR and is Involved in Hepatitis C Virus Binding

Structural insights into hepatitis C virus receptor binding and entry

Lectin microarray and mass spectrometric analysis of hepatitis C proteins reveals N-linked glycosylation.

Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans

Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions.

The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines